Open Access Open Access  Restricted Access Subscription or Fee Access

Opioid overdose protection: An inevitable need to address an alarming epidemic

Beatrice Setnik, PhD

Abstract


-


Full Text:

PDF

References


Centers for Disease Control and Prevention: Drug overdose deaths in the United States continue to increase in 2015. Available at: https://www.cdc.gov/drugoverdose/epidemic/index.html. Accessed February 15, 2017.

US Department of Health and Human Services: Food and Drug Administration. Center for Drug Evaluation and Research: Abuse-Deterrent Opioids – Evaluation and Labeling. Guidance for Industry. April 2015.

US Department of Health and Human Services: Food and Drug Administration: Fact Sheet–FDA Opioids Action Plan. Available at: http://www.fda.gov/NewsEvents/Newsroom/FactSheets/ucm484714.htm. Accessed February 15, 2017.

Patent PCT/US2015/014690: Abuse-Resistant Drug Formulations with Built-In Overdose Protection. Kashiv Pharma, LLC. Available at: http://patents.justia.com/patent/20160346274. Accessed August 3, 2017.

Cashman JN, Dolin SJ: Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data. Br J Anaesth. 2004; 93(2): 212-223.

Overdyk FJ, Carter R, Maddox RR, et al.: Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesth Analg. 2007; 105(2): 412-418.

Sivilotti M, Messenger DW, van Vlymen J, et al.: A comparative evaluation of capnometry versus pulse oximetry during procedural sedation and analgesia on room air. CJEM. 2010; 12(5): 397-404.

Setnik B, Cone EJ: Establishing “abuse-deterrence equivalence” for generic abuse-deterrent opioid formulations: A proposed development framework. J Opioid Manag. 2016; 12(2): 96-100.




DOI: http://dx.doi.org/10.5055/jom.2017.0414

Refbacks

  • There are currently no refbacks.
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR